Agios Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $211.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $3.5M | 1.7% |
| Other | $119.4M | 56.3% |
| Net Cash Flow | $89.0M | 42.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $211.9M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $3.5M | 1.7% |
| Other | $119.4M | 56.3% |
| Net Cash Flow | $89.0M | 42.0% |